• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铜绿假单胞菌骨髓炎的抗生素耐药实验模型。

An antibiotic resistant experimental model of Pseudomonas osteomyelitis.

作者信息

Nelson D R, Buxton T B, Luu Q N, Rissing J P

机构信息

VA Medical Center, Infectious Disease Laboratory, Augusta, GA 30910.

出版信息

Infection. 1990 Jul-Aug;18(4):246-8. doi: 10.1007/BF01643399.

DOI:10.1007/BF01643399
PMID:2210859
Abstract

We report a model of chronic Pseudomonas aeruginosa osteomyelitis in the rat that was reproducible, simple and inexpensive. No promoting agent was required to cause infection. Infected animals yielded consistent pseudomonal colony counts (log): 4.98 +/- 0.32 (SD)/g cortical tibia (n = 16). The 95% confidence interval of the mean was 4.83-5.14. The inoculum required to infect 50% of challenged rats (ID50) was log 4.0; the ID 100 was log 6.4. Ceftazidime (50 mg/kg/8 h, subcutaneously), alone and in combination with tobramycin (40 mg/kg/12 h, subcutaneously), produced no significant change in quantitative bacterial count or gross bone pathology when used to treat established disease.

摘要

我们报道了一种大鼠慢性铜绿假单胞菌骨髓炎模型,该模型具有可重复性、操作简单且成本低廉的特点。无需促发剂即可引发感染。感染动物的假单胞菌菌落计数(对数)一致:胫骨干皮质骨为4.98±0.32(标准差)/克(n = 16)。均值的95%置信区间为4.83 - 5.14。感染50%受试大鼠所需的接种量(ID50)为对数4.0;ID100为对数6.4。当用于治疗已确诊疾病时,头孢他啶(50毫克/千克/8小时,皮下注射)单独使用或与妥布霉素(40毫克/千克/12小时,皮下注射)联合使用,在细菌定量计数或大体骨病理学方面均未产生显著变化。

相似文献

1
An antibiotic resistant experimental model of Pseudomonas osteomyelitis.铜绿假单胞菌骨髓炎的抗生素耐药实验模型。
Infection. 1990 Jul-Aug;18(4):246-8. doi: 10.1007/BF01643399.
2
In vivo efficacy of humanised intermittent versus continuous ceftazidime in combination with tobramycin in an experimental model of pseudomonal pneumonia.在铜绿假单胞菌肺炎实验模型中,人源化间歇给药与持续给药的头孢他啶联合妥布霉素的体内疗效。
Int J Antimicrob Agents. 2008 Dec;32(6):494-8. doi: 10.1016/j.ijantimicag.2008.07.010. Epub 2008 Sep 18.
3
Use of ceftazidime-impregnated polymethyl methacrylate beads in the treatment of Pseudomonas osteomyelitis.使用头孢他啶浸渍的聚甲基丙烯酸甲酯珠治疗铜绿假单胞菌骨髓炎。
J Foot Surg. 1989 Nov-Dec;28(6):542-6.
4
Activities of tobramycin and azlocillin alone and in combination against experimental osteomyelitis caused by Pseudomonas aeruginosa.妥布霉素和阿洛西林单独及联合应用对铜绿假单胞菌所致实验性骨髓炎的抗菌活性。
Antimicrob Agents Chemother. 1982 Jan;21(1):62-5. doi: 10.1128/AAC.21.1.62.
5
Once versus thrice daily tobramycin alone and in combination with ceftazidime, ciprofloxacin and imipenem in an in vitro pharmacodynamic model.在体外药效学模型中,妥布霉素单独使用以及与头孢他啶、环丙沙星和亚胺培南联合使用时,每日一次与每日三次的比较。
Chemotherapy. 1998 Jan-Feb;44(1):1-6. doi: 10.1159/000007083.
6
Successful treatment of extensively drug-resistant Pseudomonas aeruginosa osteomyelitis using a colistin- and tobramycin-impregnated PMMA spacer.采用多粘菌素和妥布霉素载药 PMMA spacer 成功治疗广泛耐药铜绿假单胞菌骨髓炎。
Int J Antimicrob Agents. 2014 Oct;44(4):363-6. doi: 10.1016/j.ijantimicag.2014.05.023. Epub 2014 Aug 13.
7
Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.痰液抗生素浓度:对囊性纤维化肺部感染治疗的意义
Pediatr Pulmonol. 2007 Nov;42(11):1008-17. doi: 10.1002/ppul.20671.
8
The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis.美罗培南与妥布霉素联合用药对比头孢他啶与妥布霉素联合用药治疗囊性纤维化患者急性肺部加重的疗效和安全性。
Chest. 2005 Oct;128(4):2336-46. doi: 10.1378/chest.128.4.2336.
9
Clarithromycin destroys biofilms and enhances bactericidal agents in the treatment of Pseudomonas aeruginosa osteomyelitis.克拉霉素在治疗铜绿假单胞菌骨髓炎时可破坏生物膜并增强杀菌剂的作用。
Clin Orthop Relat Res. 2005 Jan(430):171-5.
10
Ciprofloxacin as therapy for experimental osteomyelitis caused by Pseudomonas aeruginosa.环丙沙星治疗铜绿假单胞菌引起的实验性骨髓炎。
J Infect Dis. 1985 Feb;151(2):291-4. doi: 10.1093/infdis/151.2.291.

引用本文的文献

1
A Journey into Animal Models of Human Osteomyelitis: A Review.人类骨髓炎动物模型研究进展:综述
Microorganisms. 2022 May 31;10(6):1135. doi: 10.3390/microorganisms10061135.
2
Infected animal models for tissue engineering.用于组织工程的感染动物模型。
Methods. 2015 Aug;84:17-24. doi: 10.1016/j.ymeth.2015.03.025. Epub 2015 Apr 2.
3
[Animal models of osteomyelitis].[骨髓炎的动物模型]

本文引用的文献

1
Experimental osteomyelitis caused by Pseudomonas aeruginosa.由铜绿假单胞菌引起的实验性骨髓炎。
J Infect Dis. 1980 Jan;141(1):71-5. doi: 10.1093/infdis/141.1.71.
2
Estimation of endpoints in biological systems.生物系统中终点的评估。
Comput Biol Med. 1984;14(4):377-84. doi: 10.1016/0010-4825(84)90038-6.
3
Experimental osteomyelitis. I. A description of the model.实验性骨髓炎。I. 模型描述。
Orthopade. 2004 Mar;33(3):260-6. doi: 10.1007/s00132-003-0608-x.
J Infect Dis. 1970 Nov;122(5):410-8. doi: 10.1093/infdis/122.5.410.
4
Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects.骨髓炎:临床特征、治疗考量及特殊方面的综述
N Engl J Med. 1970 Jan 22;282(4):198-206. doi: 10.1056/NEJM197001222820406.
5
Experimental pseudomonas osteomyelitis: treatment with sisomicin and carbenicillin.实验性假单胞菌骨髓炎:西索米星和羧苄西林治疗
J Bone Joint Surg Am. 1974 Oct;56(7):1452-8.
6
Model of experimental chronic osteomyelitis in rats.大鼠实验性慢性骨髓炎模型
Infect Immun. 1985 Mar;47(3):581-6. doi: 10.1128/iai.47.3.581-586.1985.
7
[An experimental study on pyogenic osteomyelitis with special reference to polymicrobial infections].[关于化脓性骨髓炎的实验研究,特别涉及混合感染]
Nihon Seikeigeka Gakkai Zasshi. 1985 Apr;59(4):429-41.
8
Infections due to gram-negative bacteria: an overview.革兰氏阴性菌感染概述。
Rev Infect Dis. 1985 Nov-Dec;7 Suppl 4:S778-82. doi: 10.1093/clinids/7.supplement_4.s778.
9
Ciprofloxacin as therapy for experimental osteomyelitis caused by Pseudomonas aeruginosa.环丙沙星治疗铜绿假单胞菌引起的实验性骨髓炎。
J Infect Dis. 1985 Feb;151(2):291-4. doi: 10.1093/infdis/151.2.291.
10
Ofloxacin therapy for experimental osteomyelitis caused by Pseudomonas aeruginosa.氧氟沙星治疗铜绿假单胞菌引起的实验性骨髓炎。
J Infect Dis. 1987 Apr;155(4):823-5. doi: 10.1093/infdis/155.4.823.